Preferred Pharmaceuticals, Inc.: Drug Recall
Recall #D-0239-2026 · 11/17/2025
Class II: Risk
Recall Details
- Recall Number
- D-0239-2026
- Classification
- Class II
- Product Type
- Drug
- Recalling Firm
- Preferred Pharmaceuticals, Inc.
- Status
- Ongoing
- Date Initiated
- 11/17/2025
- Location
- Anaheim, CA, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 575 1x10 Foil Blister Packs
Reason for Recall
Defective container: Preferred Pharmaceuticals received a letter from the manufacturer Glenmark, that the blister packs are not fully sealed and tablets falling out. Preferred Pharmaceuticals purchased the finished product and repackaged the product for sale.
Product Description
Ondansetron ODT Tablets, USP 4mg, 1x10 unit dose tablets, Mfg: Glenmark Pharmaceuticals Limited, Repackaged by Preferred Pharmaceuticals NDC 68788-8666-01
Distribution Pattern
Natinowide in the USA
Other Recalls by Preferred Pharmaceuticals, Inc.
- Class II: Risk 04/18/2025
- Class II: Risk 08/08/2024
- Class II: Risk 05/10/2024
- Class II: Risk 06/26/2023
- Class II: Risk 03/27/2023
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.